# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-25-098525
Filing Date
2025-04-28
Accepted
2025-04-28 08:23:29
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d783418dars.pdf | ARS | 7709888
| Complete submission text file | 0001193125-25-098525.txt |  | 10571241

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38944 | Film No.: 25876056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)